[Strategy for cardiac arrhythmias in acute coronary syndrome]

Kaoru Sugi1

  • 1Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.

Insights

Acute coronary syndrome can cause dangerous heart rhythms like ventricular tachycardia and atrial fibrillation. Potassium channel blockers are increasingly used to prevent these arrhythmias, with specific drug choices depending on the type.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Context:

  • Acute coronary syndrome (ACS) is frequently associated with cardiac arrhythmias due to myocardial ischemia and electrical instability.
  • Ventricular tachycardia (VT) is a critical arrhythmia in ACS, potentially degenerating into ventricular fibrillation (VF), necessitating immediate intervention.
  • Atrial fibrillation (AF) also occurs in ACS patients, often worsening hemodynamic stability.

Purpose:

  • To discuss the management of arrhythmias in acute coronary syndrome.
  • To highlight the role of potassium channel blockers in preventing ventricular tachyarrhythmias.
  • To outline therapeutic options for preventing and terminating atrial fibrillation in the context of ACS.

Summary:

  • Acute coronary syndrome (ACS) leads to arrhythmias, primarily ventricular tachycardia (VT) progressing to ventricular fibrillation (VF), requiring direct current cardioversion.
  • Potassium channel blockers, such as nifekalant and amiodarone, are increasingly utilized in Japan for preventing VT/VF.
  • Atrial fibrillation (AF) in ACS can compromise hemodynamics; drugs like aprindine, amiodarone, or bepridil are options for post-cardioversion prevention.

Impact:

  • Provides guidance on selecting antiarrhythmic drugs for managing life-threatening arrhythmias in acute coronary syndrome.
  • Emphasizes the importance of preventing recurrent arrhythmias to improve patient outcomes and stability.
  • Contributes to the understanding of pharmacological strategies for cardiac rhythm management in ACS patients.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...